Current Portfolio
QurAlis
QurAlis develops precision medicines to treat ALS and other neurodegenerative diseases. Its pipeline targets disease-causing mechanisms such as motor neuron hyperexcitability.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP Dementia Fund
- Entry
2022
Website
Responsible Partner
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.